- Home
- GOOD vs KALV Comparison
GOOD vs KALV Comparison
Compare GOOD & KALV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOOD
- KALV
- Stock Information
- Founded
- GOOD 2003
- KALV N/A
- Country
- GOOD United States
- KALV United States
- Employees
- GOOD N/A
- KALV N/A
- Industry
- GOOD Real Estate Investment Trusts
- KALV Biotechnology: Pharmaceutical Preparations
- Sector
- GOOD Real Estate
- KALV Health Care
- Exchange
- GOOD Nasdaq
- KALV Nasdaq
- Market Cap
- GOOD 699.6M
- KALV 563.1M
- IPO Year
- GOOD N/A
- KALV N/A
- Fundamental
- Price
- GOOD $14.91
- KALV $11.31
- Analyst Decision
- GOOD Hold
- KALV Strong Buy
- Analyst Count
- GOOD 1
- KALV 8
- Target Price
- GOOD $15.00
- KALV $24.83
- AVG Volume (30 Days)
- GOOD 604.6K
- KALV 567.9K
- Earning Date
- GOOD 05-05-2025
- KALV 03-12-2025
- Dividend Yield
- GOOD 8.01%
- KALV N/A
- EPS Growth
- GOOD N/A
- KALV N/A
- EPS
- GOOD 0.27
- KALV N/A
- Revenue
- GOOD $149,388,000.00
- KALV N/A
- Revenue This Year
- GOOD $3.44
- KALV N/A
- Revenue Next Year
- GOOD $2.60
- KALV N/A
- P/E Ratio
- GOOD $56.24
- KALV N/A
- Revenue Growth
- GOOD 1.22
- KALV N/A
- 52 Week Low
- GOOD $12.85
- KALV $7.30
- 52 Week High
- GOOD $17.88
- KALV $15.50
- Technical
- Relative Strength Index (RSI)
- GOOD 40.53
- KALV 46.03
- Support Level
- GOOD $14.74
- KALV $11.05
- Resistance Level
- GOOD $15.04
- KALV $12.50
- Average True Range (ATR)
- GOOD 0.22
- KALV 0.55
- MACD
- GOOD 0.03
- KALV -0.19
- Stochastic Oscillator
- GOOD 60.66
- KALV 15.09
About GOOD Gladstone Commercial Corporation Real Estate Investment Trust
Gladstone Commercial Corp is a real estate investment trust, which engages in investing and owning net leased industrial, commercial, and retail real property and making long-term industrial and commercial mortgage loans. Its portfolio consists of single-tenant commercial, industrial real properties, and medical properties nationwide. Its principal investment objectives are to generate income from rental properties.
About KALV KalVista Pharmaceuticals Inc.
KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema; and oral plasma kallikrein inhibitors. Geographically it operates throughout the region of the United States. The company is also conducting preclinical development on a novel, oral, Factor XIIa inhibitor program.